BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31897962)

  • 1. Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis.
    Cheng N; He Y; Dang A; Lv N; Wang X; Li H
    Clin Rheumatol; 2020 May; 39(5):1591-1599. PubMed ID: 31897962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.
    Isakova T; Houston J; Santacruz L; Schiavenato E; Somarriba G; Harmon WG; Lipshultz SE; Miller TL; Rusconi PG
    Pediatr Nephrol; 2013 Oct; 28(10):2035-42. PubMed ID: 23740037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.
    Falkner B; Keith SW; Gidding SS; Langman CB
    J Am Soc Hypertens; 2017 Aug; 11(8):480-487. PubMed ID: 28456498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients.
    Shibata K; Fujita S; Morita H; Okamoto Y; Sohmiya K; Hoshiga M; Ishizaka N
    PLoS One; 2013; 8(9):e73184. PubMed ID: 24039882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.
    Jovanovich A; Ix JH; Gottdiener J; McFann K; Katz R; Kestenbaum B; de Boer IH; Sarnak M; Shlipak MG; Mukamal KJ; Siscovick D; Chonchol M
    Atherosclerosis; 2013 Nov; 231(1):114-9. PubMed ID: 24125420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
    Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
    Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal artery involvement is associated with increased morbidity but not mortality in Takayasu arteritis: a matched cohort study of 215 patients.
    Thakare DR; Mishra P; Rathore U; Singh K; Dixit J; Qamar T; Behera MR; Jain N; Ora M; Bhadauria DS; Gambhir S; Kumar S; Agarwal V; Misra DP
    Clin Rheumatol; 2024 Jan; 43(1):67-80. PubMed ID: 38051415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis.
    Zanwar A; Jain A; Gupta L; Chaurasia S; Kumar S; Misra DP; Misra R
    Clin Rheumatol; 2018 Dec; 37(12):3439-3442. PubMed ID: 29998368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.
    Montford JR; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Am J Nephrol; 2013; 37(3):183-90. PubMed ID: 23428834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.
    Ali FN; Falkner B; Gidding SS; Price HE; Keith SW; Langman CB
    J Pediatr; 2014 Oct; 165(4):738-43.e1. PubMed ID: 25063724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Serum Uric Acid Independently Associated With Left Ventricular Mass Index, Ejection Fraction, and B-Type Natriuretic Peptide Among Female and Male Cardiac Patients?
    Yamauchi Y; Fujita SI; Shibata K; Morita H; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
    Int Heart J; 2017 Aug; 58(4):562-569. PubMed ID: 28701671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Risk Factors for Active Tuberculosis in Takayasu Arteritis: A Single-Center Case-Control Study.
    Zhou J; Ji R; Zhu R; Zhou J; Li J; Tian X; Chen Y; Zheng Y
    Front Immunol; 2021; 12():749317. PubMed ID: 34777361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
    Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
    Akhabue E; Wong M; Mehta R; Isakova T; Wolf M; Yancy C; Gutierrez OM; Carnethon M
    Am Heart J; 2022 Mar; 245():10-18. PubMed ID: 34861237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.